Clinical trial

JMT106 Injection in the Treatment of Advanced Solid Tumors

NCT07275073

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-09-25

PhasePHASE1

Study timeline

Study start (actual)2025-09-25Date precision: day

Registry last updated2025-12-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Solid Tumorunresolved

Lung Squamous Cell Carcinomaunresolved

Hepatocellular Carcinomaunresolved

Interventions

JMT106 InjectionDRUG

Sponsors & collaborators

Shanghai JMT-Bio Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07275073 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.